Search Results - "Zang, Chuanbo"

Tofacitinib versus Methotrexate in Rheumatoid Arthritis by Lee, Eun Bong, Fleischmann, Roy, Hall, Stephen, Wilkinson, Bethanie, Bradley, John D, Gruben, David, Koncz, Tamas, Krishnaswami, Sriram, Wallenstein, Gene V, Zang, Chuanbo, Zwillich, Samuel H, van Vollenhoven, Ronald F

“…In patients with rheumatoid arthritis, tofacitinib was associated with greater reductions in signs and symptoms than methotrexate. Herpes zoster infections and…”
Get full text

Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial by Bissonnette, Robert, Pavel, Ana B., Diaz, Aisleen, Werth, John L., Zang, Chuanbo, Vranic, Ivana, Purohit, Vivek S., Zielinski, Michael A., Vlahos, Bonnie, Estrada, Yeriel D., Saint-Cyr Proulx, Etienne, Ports, William C., Guttman-Yassky, Emma

“…Crisaborole ointment 2% is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic dermatitis (AD). The mechanism of action…”
Get full text

Effects of different levels of controlled hypotension on regional cerebral oxygen saturation and postoperative cognitive function in patients undergoing total knee arthroplasty by Zhao, Yajuan, Zang, Chuanbo, Ren, Shengjie, Fu, Jianbin, Liu, Ning, Zhou, Ziyu, Lang, Bao

“…Background Controlled hypotension technique was usually used to reduce intraoperative bleeding, and it could improve visualization of the surgical field during…”
Get full text

A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis by Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Zang, Chuanbo, Alvarez, Daniel, Fletcher, Tracey, Wajdula, Joseph, Yuasa, Hirotoshi, Vlahos, Bonnie

“…Objectives The aim of this phase 3, double-blind study was to compare the radiographic and clinical effects of etanercept (ETN) versus methotrexate (MTX) over…”
Get full text

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis by Fowler, Joseph, Sugarman, Jeffrey, Sher, Lawrence, Zang, Chuanbo, Werth, John L., Myers, Daniela E., Graham, Daniela, Marfo, Alexander Agyei, Takiya, Liza

“…Introduction Using data from three clinical trials, the effect of crisaborole treatment on sleep outcomes for pediatric patients with atopic dermatitis (AD)…”
Get full text

Effect of opioid-free anesthesia on the incidence of postoperative nausea and vomiting: A meta-analysis of randomized controlled studies by Zhang, Yanan, Ma, Dandan, Lang, Bao, Zang, Chuanbo, Sun, Zenggang, Ren, Shengjie, Chen, Huayong

“…Background: Research on opioid-free anesthesia has increased in recent years; however, it has never been determined whether it is more beneficial than opioid…”
Get full text

Correlation between burst suppression and postoperative delirium in elderly patients: a prospective study by Ren, Shengjie, Zang, Chuanbo, Yuan, Fang, Yan, Xuemei, Zhang, Yanan, Yuan, Shu, Sun, Zenggang, Lang, Bao

“…Objective To explore the correlation between intraoperative burst suppression (BS) and postoperative delirium (POD) in elderly patients, and provide more ideas…”
Get full text

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1) by Schlessinger, Joel, Shepard, Julie S., Gower, Richard, Su, John C., Lynde, Charles, Cha, Amy, Ports, William C., Purohit, Vivek, Takiya, Liza, Werth, John L., Zang, Chuanbo, Vlahos, Bonnie

“…Background Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic dermatitis (AD). Objectives…”
Get full text

Early Cognitive Dysfunction in Elderly Patients after Total Knee Arthroplasty: An Analysis of Risk Factors and Cognitive Functional Levels by Ren, Shengjie, Yuan, Fang, Yuan, Shu, Zang, Chuanbo, Zhang, Yanan, Lang, Bao

“…Background. Cognitive dysfunction after total knee arthroplasty (TKA) is very common in elderly patients. Postoperative cognitive dysfunction (POCD), as a form…”
Get full text

42037 Phase 2a Study of Efficacy and Safety of Crisaborole in Patients with Stasis Dermatitis Using a Decentralized Evaluation Method by Silverberg, Jonathan I., Kirsner, Robert S., Margolis, David, Tharp, Michael, Myers, Daniela E., Annis, Karen, Graham, Daniela, Zang, Chuanbo, Vlahos, Bonnie L., Sanders, Paul

Get full text

26993 Efficacy and safety of crisaborole by body region in infants with mild-to-moderate atopic dermatitis by Schlessinger, Joel, Shepard, Julie S., Forsha, Douglass W., Zaenglein, Andrea L., Werth, John L., Zang, Chuanbo, Cha, Amy, Takiya, Liza

Get full text

Efficacy Trends With Continuous Long-Term Use of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis (AD) by Lebwohl, Mark, Hebert, Adelaide, Takiya, Liza, Miller, Lauren, Werth, John, Zang, Chuanbo, Sanders, Paul, Geng, Bob

Get full text

Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study by Silverberg, Jonathan I., Kirsner, Robert S., Margolis, David J., Tharp, Michael, Myers, Daniela E., Annis, Karen, Graham, Daniela, Zang, Chuanbo, Vlahos, Bonnie L., Sanders, Paul

“…Crisaborole ointment, 2%, is a nonsteroidal topical phosphodiesterase 4 inhibitor approved for the treatment of mild-to-moderate atopic dermatitis. To evaluate…”
Get full text

288 Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial by Gower, Richard, Xu, JinHua, Alam, Maryam S, Su, John C, Myers, Daniela E, Sanders, Paul, Vlahos, Bonnie, Zang, Chuanbo, Lan, Jar, Werth, John 

“…Abstract Treatments for atopic dermatitis (AD) often fail to achieve lasting disease control despite patient adherence, with safety concerns limiting the…”
Get full text

Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With Comorbid Allergic Rhinitis or Asthma by Spergel, Jonathan, Blaiss, Michael, Lio, Peter, Kessel, Aharon, Takiya, Liza, Werth, John, O'Connell, Michael, Zang, Chuanbo, Cork, Michael

Get full text

Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin by Kim, Madeline, Del Duca, Ester, Cheng, Julia, Carroll, Britta, Facheris, Paola, Estrada, Yeriel, Cha, Amy, Werth, John, Bissonnette, Robert, Nocka, Karl, Zang, Chuanbo, Pavel, Ana B., Guttman-Yassky, Emma

“…Safe and effective long-term topical treatments for atopic dermatitis (AD) remain limited. In this phase 2a, single-center, intrapatient, and…”
Get full text

14248 Efficacy and safety trends with continuous long-term use of 2% crisaborole ointment in patients with mild to moderate atopic dermatitis by Lebwohl, Mark G., Hebert, Adelaide A., Takiya, Liza, Miller, Lauren E., Werth, John L., Zang, Chuanbo, Sanders, Paul, Geng, Bob

Get full text

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial by Van den Bosch, Filip, Wei, James Cheng-Chung, Nash, Peter, Blanco, Francisco J, Graham, Daniela, Zang, Chuanbo, Arthur, Edmund, Borlenghi, Cecilia, Tsekouras, Vassilis, Vlahos, Bonnie, Deodhar, Atul

“…RE-EMBARK investigated etanercept (ETN) withdrawal and retreatment in patients with nonradiographic axial spondyloarthritis (nr-axSpA) achieving inactive…”
Get full text

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis by Vojinović, Jelena, Foeldvari, Ivan, Dehoorne, Joke, Panaviene, Violeta, Susic, Gordana, Horneff, Gerd, Stanevicha, Valda, Kobusinska, Katarzyna, Zuber, Zbigniew, Dobrzyniecka, Bogna, Akikusa, Jonathan, Avcin, Tadej, Borlenghi, Cecilia, Arthur, Edmund, Tatulych, Svitlana Y, Zang, Chuanbo, Tsekouras, Vassilis, Vlahos, Bonnie, Martini, Alberto, Ruperto, Nicolino

“…CLIPPER2 was an 8-year, open-label extension of the phase 3b, 2-year CLIPPER study on the safety and efficacy of etanercept in patients with JIA, categorized…”
Get full text

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study by Horneff, Gerd, Burgos-Vargas, Ruben, Constantin, Tamas, Foeldvari, Ivan, Vojinovic, Jelena, Chasnyk, Vyacheslav G, Dehoorne, Joke, Panaviene, Violeta, Susic, Gordana, Stanevica, Valda, Kobusinska, Katarzyna, Zuber, Zbigniew, Mouy, Richard, Rumba-Rozenfelde, Ingrida, Breda, Luciana, Dolezalova, Pavla, Job-Deslandre, Chantal, Wulffraat, Nico, Alvarez, Daniel, Zang, Chuanbo, Wajdula, Joseph, Woodworth, Deborah, Vlahos, Bonnie, Martini, Alberto, Ruperto, Nicolino

“…To investigate the efficacy and safety of etanercept (ETN) in paediatric subjects with extended oligoarticular juvenile idiopathic arthritis (eoJIA),…”
Get more information